Camouflaging in ADHD: the need for construct validation before clinical adoption
The British Journal of Psychiatry · 2026-10 · 229 (4) · 366-369
DOI: 10.1192/bjp.2026.10577 ↗Kurz gefasst
Editorial in der Zeitschrift The British Journal of Psychiatry, online erschienen am 02.03.2026. Verfasst von Marios Adamou. Beteiligte Einrichtung: School of Human and Health Sciences, University of Huddersfield, UK. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Executive Function. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Abstract (Originalsprache)
This editorial argues that camouflaging, as developed in autism research, does not transfer coherently to attention-deficit hyperactivity disorder (ADHD). The executive functions required for sustained symptom concealment are precisely those impaired in ADHD. Current measures lack ADHD-specific validity, and compensatory behaviours should not be reclassified as camouflaging without dedicated theory, operational definitions and validated measurement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Human and Health Sciences, University of Huddersfield, UK.
ORCID-Profile: Marios Adamou
Zitieren
APA
Adamou, M. (2026). Camouflaging in ADHD: the need for construct validation before clinical adoption. The British Journal of Psychiatry, 229(4), 366-369. https://doi.org/10.1192/bjp.2026.10577
Vancouver
Adamou M. Camouflaging in ADHD: the need for construct validation before clinical adoption. The British Journal of Psychiatry. 2026;229(4):366-369. doi:10.1192/bjp.2026.10577
BibTeX
@article{Adamou2026,
author = {Adamou, Marios},
title = {Camouflaging in ADHD: the need for construct validation before clinical adoption},
journal = {The British Journal of Psychiatry},
year = {2026},
volume = {229},
number = {4},
pages = {366--369},
doi = {10.1192/bjp.2026.10577}
}
EUVIMED